Anixa Biosciences Inc SEC filings ANIX
Anixa Biosciences Inc has 983 filings in SEC EDGAR's recent list, going back to Jun 9, 1995. Its latest annual report, Form 10-K, was filed on Jan 12, 2026 for the period ended Oct 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 9, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Mar 11, 2026 (shareholder vote results, regulation fd disclosure). The company's fiscal year ends on October 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Oct 26, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 22, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 23, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Sep 9, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 15, 2026 |
| 4 | Insider transaction | Jul 13, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| 10-Q | Quarterly report | Jun 10, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 11, 2026 | Mar 10, 2026 |
| 10-Q | Quarterly report | Mar 9, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 28, 2026 |
| DEF 14A | Proxy statement | Jan 28, 2026 | Jan 28, 2026 |
| S-8 | Employee stock plan registration | Jan 12, 2026 | — |
| 10-K | Annual report | Jan 12, 2026 | Oct 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 6, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 30, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| S-3 | Shelf registration | Sep 10, 2025 | — |
| 10-Q | Quarterly report | Sep 10, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 31, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 21, 2025 | Jul 18, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 14, 2025 | Jul 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 6, 2025 | — |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 28, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 21, 2025 | Mar 20, 2025 |
| 10-Q | Quarterly report | Mar 11, 2025 | Jan 31, 2025 |
| DEF 14A | Proxy statement | Feb 6, 2025 | Oct 31, 2024 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 27, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Jan 15, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 15, 2025 | Jan 15, 2025 |
| S-8 | Employee stock plan registration | Jan 10, 2025 | — |
| 10-K | Annual report | Jan 10, 2025 | Oct 31, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 3, 2025 | — |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 8, 2024 | Nov 8, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 22, 2024 |
| 10-Q | Quarterly report | Sep 6, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Jul 29, 2024 | Jul 25, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 26, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 10-Q | Quarterly report | Jun 4, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 8, 2024 | May 3, 2024 |
| SC 13D | Ownership over 5% (active) | May 3, 2024 | — |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | Apr 10, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 22, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 15, 2024 |
| 10-Q | Quarterly report | Mar 12, 2024 | Jan 31, 2024 |
| DEF 14A | Proxy statement | Feb 8, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 12, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 12, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 12, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 12, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 16, 2024 | — |
| S-8 | Employee stock plan registration | Jan 16, 2024 | — |
| 10-K | Annual report | Jan 16, 2024 | Oct 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2023 | Dec 6, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 4 | Insider transaction | Oct 11, 2023 | Oct 10, 2023 |
| 10-Q | Quarterly report | Sep 6, 2023 | Jul 31, 2023 |
| 4 | Insider transaction | Jul 31, 2023 | Jul 27, 2023 |
| 4 | Insider transaction | Jul 31, 2023 | Jul 28, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 20, 2023 |
| 10-Q | Quarterly report | Jun 14, 2023 | Apr 30, 2023 |
| 4 | Insider transaction | May 1, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2023 | Apr 17, 2023 |
| 10-Q | Quarterly report | Mar 17, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 10, 2023 | Mar 9, 2023 |
| DEF 14A | Proxy statement | Jan 27, 2023 | Jan 27, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Jan 3, 2023 |
| S-8 | Employee stock plan registration | Jan 4, 2023 | — |
| 10-K | Annual report | Jan 4, 2023 | Oct 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2022 | Dec 8, 2022 |
| 4 | Insider transaction | Nov 1, 2022 | Oct 31, 2022 |
| 4 | Insider transaction | Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2022 | Sep 28, 2022 |
| EFFECT | Filing | Sep 19, 2022 | — |
| 4 | Insider transaction | Sep 16, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 16, 2022 | Sep 14, 2022 |
| CORRESP | Letter to the SEC | Sep 15, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2022 | — |
| DEL AM | Filing | Sep 12, 2022 | — |
| S-3 | Shelf registration | Sep 9, 2022 | — |
| 10-Q | Quarterly report | Sep 9, 2022 | Jul 31, 2022 |
| 8-K |
Current report
Other events
|
Aug 17, 2022 | Aug 15, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 24, 2022 |
| 10-Q | Quarterly report | Jun 10, 2022 | Apr 30, 2022 |
| 4 | Insider transaction | May 2, 2022 | Apr 29, 2022 |
| 4 | Insider transaction | Apr 27, 2022 | Apr 26, 2022 |
| 4 | Insider transaction | Apr 22, 2022 | Apr 21, 2022 |
| 4 | Insider transaction | Apr 21, 2022 | Apr 20, 2022 |
| 4 | Insider transaction | Apr 15, 2022 | Apr 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2022 | Apr 14, 2022 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 10-Q | Quarterly report | Mar 11, 2022 | Jan 31, 2022 |
| DEF 14A | Proxy statement | Jan 28, 2022 | Jan 28, 2022 |
| 4 | Insider transaction | Jan 13, 2022 | Jan 12, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 11, 2022 |
| 4 | Insider transaction | Jan 11, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 10, 2022 | Jan 7, 2022 |
| 4 | Insider transaction | Jan 7, 2022 | Jan 7, 2022 |
| S-8 | Employee stock plan registration | Jan 4, 2022 | — |
| 10-K | Annual report | Jan 4, 2022 | Oct 31, 2021 |
| 8-K | Current report | Dec 9, 2021 | Dec 7, 2021 |
| 4 | Insider transaction | Nov 2, 2021 | Oct 29, 2021 |
| 4 | Insider transaction | Nov 1, 2021 | Oct 29, 2021 |
| 4 | Insider transaction | Nov 1, 2021 | Oct 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Other events
|
Oct 4, 2021 | Oct 1, 2021 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 3, 2021 | — |
| 10-Q | Quarterly report | Sep 1, 2021 | Jul 31, 2021 |
| 4 | Insider transaction | Jul 28, 2021 | Jul 26, 2021 |
| 4 | Insider transaction | Jul 27, 2021 | Jul 23, 2021 |
| 4 | Insider transaction | Jul 27, 2021 | Jul 23, 2021 |
| 4 | Insider transaction | Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 19, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 15, 2021 |
| 4 | Insider transaction | Jul 15, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Agreement ended
|
Jun 16, 2021 | Jun 16, 2021 |
| 10-Q | Quarterly report | Jun 10, 2021 | Apr 30, 2021 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 10, 2021 | — |
| 4 | Insider transaction | Jun 2, 2021 | Jun 1, 2021 |
| 4 | Insider transaction | Jun 2, 2021 | Jun 1, 2021 |
| 4 | Insider transaction | Jun 2, 2021 | Jun 1, 2021 |
| 4 | Insider transaction | Jun 2, 2021 | Jun 1, 2021 |
| 4 | Insider transaction | Jun 2, 2021 | May 31, 2021 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
May 27, 2021 | May 21, 2021 |
| 4 | Insider transaction | May 4, 2021 | Apr 30, 2021 |
| 4 | Insider transaction | Apr 23, 2021 | Apr 23, 2021 |
| 4 | Insider transaction | Apr 20, 2021 | Apr 20, 2021 |
| 4 | Insider transaction | Apr 20, 2021 | Apr 19, 2021 |
| DEF 14A | Proxy statement | Apr 9, 2021 | Apr 9, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 2, 2021 | Mar 29, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2021 | Mar 30, 2021 |
| 4 | Insider transaction | Mar 26, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 26, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 25, 2021 | Mar 25, 2021 |
| 4 | Insider transaction | Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 24, 2021 | Mar 22, 2021 |
| 424B5 | Prospectus supplement | Mar 24, 2021 | — |
| FWP | Free writing prospectus | Mar 23, 2021 | — |
| FWP | Free writing prospectus | Mar 22, 2021 | — |
| 424B5 | Prospectus supplement | Mar 22, 2021 | — |
| 10-Q | Quarterly report | Mar 11, 2021 | Jan 31, 2021 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 5, 2021 | — |
| 4 | Insider transaction | Feb 5, 2021 | Feb 3, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANIX (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 715446
- Former names
- ITUS Corp (until Sep 27, 2018); COPYTELE INC (until Aug 27, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.